AEE
32
-3
HST
53
-4
KIM
44
-6
MNST
52
2
PVH
57
2
FE
38
-3
DHR
43
2
EQR
51
-2
BLK
41
-2
AAP
26
3
XEL
46
-4
AMAT
60
3
SE
35
10
SNA
58
-2
MCK
52
3
ORLY
64
4
NTRS
32
-7
XOM
57
-2
VIX
72
-7
CRM
42
2
AEE
32
-3
HST
53
-4
KIM
44
-6
MNST
52
2
PVH
57
2
FE
38
-3
DHR
43
2
EQR
51
-2
BLK
41
-2
AAP
26
3
XEL
46
-4
AMAT
60
3
SE
35
10
SNA
58
-2
MCK
52
3
ORLY
64
4
NTRS
32
-7
XOM
57
-2
VIX
72
-7
CRM
42
2
Financhill
Back

Catalyst Pharmaceuticals 10K Form

Sell
41

CPRX
Catalyst Pharmaceuticals

Last Price:
16.00
Seasonality Move:
5.15%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CPRX News And Ratings

See the #1 stock for the next 7 days that we like better than CPRX

CPRX Financial Statistics

Sales & Book Value

Annual Sales: $398.2M
Cash Flow: $53.33M
Price / Cash Flow: 28.14
Annual Sales: $3.62
Price / Book: 4.72

Profitability

EPS (TTM): 0.61000
Net Income (TTM): $71.41M
Gross Margin: $346.24M
Return on Equity: 20.45%
Return on Assets: 16.92%

Catalyst Pharmaceuticals Earnings Forecast

Key Catalyst Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 22 years for CPRX is 86.95%.
  • The Selling, General & Administrative Expenses for CPRX have been equal to 33.58% of Gross Profit Margin.
  • The Research & Development expenses have been 23.39% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 22 years have been positive in 10 years.

Catalyst Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Current Symbol: CPRX
CUSIP: 14888U
Website: catalystpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.88
Quick Ratio: 2.51

Price-to-Earnings

Trailing P/E Ratio: 24.67
Forward P/E Ratio: 7.29

CPRX Technical Analysis vs Fundamental Analysis

Sell
41
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy or a Sell?